MoonLake Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . MoonLake Immunotherapeutics
MLTX Stock  USD 39.65  0.98  2.53%   
MoonLake Immunotherapeuti financial statements provide useful quarterly and yearly information to potential MoonLake Immunotherapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MoonLake Immunotherapeuti financial statements helps investors assess MoonLake Immunotherapeuti's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MoonLake Immunotherapeuti's valuation are summarized below:
Market Capitalization
2.4 B
Earnings Share
(1.89)
We have found one hundred fourteen available fundamental ratios for MoonLake Immunotherapeuti, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of MoonLake Immunotherapeuti last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 3.6 B in 2025. Enterprise Value is likely to rise to about 3.4 B in 2025
Check MoonLake Immunotherapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MoonLake Immunotherapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.3 K, Other Operating Expenses of 34.1 M or Total Operating Expenses of 150.2 B, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0072. MoonLake financial statements analysis is a perfect complement when working with MoonLake Immunotherapeuti Valuation or Volatility modules.
  
Check out the analysis of MoonLake Immunotherapeuti Correlation against competitors.

MoonLake Immunotherapeuti Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets501.8 B477.9 B61.4 B
Slightly volatile
Short and Long Term Debt Total3.5 M2.8 M1.6 M
Slightly volatile
Other Current Liabilities23.6 B22.5 B2.9 B
Slightly volatile
Total Current Liabilities23.6 B22.5 B2.9 B
Slightly volatile
Cash149.7 M180.4 M52.7 M
Slightly volatile
Non Current Assets Total3.8 B3.6 B546.8 M
Slightly volatile
Cash And Short Term Investments470.4 B448 B57.4 B
Slightly volatile
Common Stock Shares Outstanding36.1 M62.9 M21.8 M
Slightly volatile
Liabilities And Stockholders Equity501.8 B477.9 B61.4 B
Slightly volatile
Non Current Liabilities Total2.2 B2.1 B269.3 M
Slightly volatile
Other Current Assets24.6 B23.4 B3 B
Slightly volatile
Total Liabilities25.8 B24.5 B3.1 B
Slightly volatile
Total Current Assets498 B474.3 B60.8 B
Slightly volatile
Short Term Debt1.3 M1.4 M1.2 M
Slightly volatile
Common Stock6.1 K6.4 K79.1 M
Slightly volatile
Other Liabilities191.9 K215.9 K235.4 K
Slightly volatile
Net Tangible Assets62.7 M44 M93.7 M
Slightly volatile
Property Plant And Equipment Net2.2 M3.6 M666.7 K
Slightly volatile
Warrants92 M103.5 M112.8 M
Slightly volatile
Accounts Payable9.1 M8.7 M2.1 M
Slightly volatile
Net Receivables3 M2.8 M555.5 K
Slightly volatile
Common Stock Total Equity6.4 K6.1 K1.5 K
Slightly volatile
Inventory1.1 M1.2 M1.3 M
Slightly volatile
Other Stockholder Equity716.5 B682.4 B87.5 B
Slightly volatile
Deferred Long Term Liabilities3.2 M3.6 M3.9 M
Slightly volatile
Net Invested Capital273.5 M446.8 M81.5 M
Slightly volatile
Property Plant And Equipment Gross2.1 M3.6 M644.2 K
Slightly volatile
Short and Long Term Debt12 M13.5 M14.7 M
Slightly volatile
Capital Stock6.1 K6.4 K84.8 K
Slightly volatile
Property Plant Equipment52.3 K56.8 K47.3 K
Slightly volatile
Noncontrolling Interest In Consolidated Entity15.9 M17.9 M19.5 M
Slightly volatile
Capital Surpluse103.4 M116.3 M126.8 M
Slightly volatile
Non Current Liabilities Other328.9 K370 K403.4 K
Slightly volatile
Other Assets0.80.90.9813
Slightly volatile

MoonLake Immunotherapeuti Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization11.3 K11.8 K145.2 K
Slightly volatile
Other Operating Expenses34.1 M62.2 M13.8 M
Slightly volatile
Total Operating Expenses150.2 B143.1 B18.3 B
Slightly volatile
Total Other Income Expense Net23.2 M22.1 M3.5 M
Slightly volatile
Selling General Administrative31.8 B30.3 B3.9 B
Slightly volatile
Selling And Marketing Expenses26.9 B25.6 B6.1 B
Slightly volatile
Research Development118.4 B112.8 B14.5 B
Slightly volatile
Cost Of Revenue11.2 K15.1 K7 K
Slightly volatile
Non Operating Income Net Other340.7 K680.5 K158.6 K
Slightly volatile
Tax Provision296.3 K282.2 K69.5 K
Slightly volatile
Reconciled Depreciation1.5 M1.4 M188.3 K
Slightly volatile

MoonLake Immunotherapeuti Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities53.9 B51.3 B6.7 B
Slightly volatile
End Period Cash Flow189.4 B180.4 B23.1 B
Slightly volatile
Stock Based Compensation7.6 B7.3 B933.4 M
Slightly volatile
Begin Period Cash Flow473.7 B451.2 B57.8 B
Slightly volatile
Depreciation1.5 B1.4 B177.4 M
Slightly volatile
Dividends Paid41.5 K46.7 K50.9 K
Slightly volatile
Change To Operating Activities2.9 M3.3 M3.6 M
Slightly volatile
Change To Liabilities2.1 M1.2 M3.2 M
Slightly volatile
Issuance Of Capital Stock49.9 M52.5 M401.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation4.0E-44.0E-49.0839
Slightly volatile
Inventory Turnover0.0030.00340.0037
Slightly volatile
Days Of Inventory On Hand77.7 K87.4 K95.3 K
Slightly volatile
Payables Turnover0.250.230.0656
Slightly volatile
Cash Per Share4.5 K4.3 K547
Slightly volatile
Days Payables Outstanding1.5 K1.6 K68.3 K
Slightly volatile
Income Quality1.530.96162.7084
Slightly volatile
Current Ratio15.3821.113415.0493
Slightly volatile
Capex Per Share0.00420.00830.006
Slightly volatile
Average Receivables328 K573.3 K244.8 K
Slightly volatile
Interest Debt Per Share0.04280.0450.1332
Pretty Stable
Debt To Assets0.00.00.0978
Pretty Stable
Operating Cycle77.7 K87.4 K95.3 K
Slightly volatile
Days Of Payables Outstanding1.5 K1.6 K68.3 K
Slightly volatile
Ebt Per Ebit1.010.930.887
Slightly volatile
Total Debt To Capitalization0.00.00.2806
Pretty Stable
Quick Ratio15.3621.113415.0441
Slightly volatile
Net Income Per E B T1.050.99770.9917
Pretty Stable
Cash Ratio0.00760.00810.5133
Very volatile
Days Of Inventory Outstanding77.7 K87.4 K95.3 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.81.00450.9893
Slightly volatile
Debt Ratio0.00.00.0978
Pretty Stable

MoonLake Immunotherapeuti Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.6 B3.4 B699 M
Slightly volatile
Enterprise Value3.4 B3.2 B651.1 M
Slightly volatile

MoonLake Fundamental Market Drivers

Cash And Short Term Investments448 B

MoonLake Upcoming Events

18th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
18th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MoonLake Immunotherapeuti Financial Statements

MoonLake Immunotherapeuti investors use historical fundamental indicators, such as MoonLake Immunotherapeuti's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MoonLake Immunotherapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-166.9 K-175.3 K
Cost Of Revenue15.1 K11.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY